CVS Health Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | $-594.0M |
| Depreciation & Amortization | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | $2.72B |
| Depreciation | $2.60B | $2.60B | $2.50B | $2.40B | $2.30B | $2.10B | $1.90B | $1.70B |
| Amortization | $1.98B | $2.03B | $1.91B | $1.79B | $2.23B | $2.34B | $2.44B | $1.01B |
| Stock-Based Compensation | $535.0M | $540.0M | $588.0M | $447.0M | $484.0M | $400.0M | $453.0M | $280.0M |
| Net Cash from Operating Activities | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | $8.87B |
| Investing Activities | ||||||||
| Capital Expenditures | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | $2.04B |
| Business Acquisitions | $436.0M | $95.0M | $16.61B | $139.0M | $146.0M | $866.0M | $444.0M | $42.23B |
| Net Cash from Investing Activities | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | $-43.29B |
| Financing Activities | ||||||||
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.63B | $2.62B | $2.60B | $2.04B |
| Stock Repurchases | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | $0 |
| Net Cash from Financing Activities | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | $36.82B |
| Net Change in Cash | $-172.0M | $359.0M | $-4.78B | $614.0M | $1.65B | $2.64B | $1.86B | $2.40B |
| Free Cash Flow | $7.81B | $6.33B | $10.40B | $13.45B | $15.75B | $13.43B | $10.39B | $6.83B |